Privia Health Group, Inc.
$24.08
▲
0.66%
2026-04-21 08:58:00
www.priviahealth.com
NMS: PRVA
Explore Privia Health Group, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.02 B
Current Price
$24.08
52W High / Low
$26.51 / $18.77
Stock P/E
131.66
Book Value
$5.96
Dividend Yield
—
ROCE
4.27%
ROE
4.03%
Face Value
—
EPS
$0.18
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
1,226
Beta
0.87
Debt / Equity
1.21
Current Ratio
1.6
Quick Ratio
1.6
Forward P/E
18.67
Price / Sales
1.32
Enterprise Value
$2.35 B
EV / EBITDA
53.25
EV / Revenue
1.11
Rating
Strong Buy
Target Price
$31.75
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Doximity, Inc. | $24.39 | 19.07 | $4.56 B | — | 20.77% | 23.82% | $76.51 / $20.55 | $5.29 |
| 2. | SCWorx Corp. | $1.05 | — | $1.18 M | — | -27.93% | -76.35% | $13.05 / $0.76 | $0.52 |
| 3. | OptimizeRx Corporation | $7.2 | 26.21 | $134.53 M | — | 7.75% | 4.18% | $22.25 / $5.54 | $6.84 |
| 4. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
| 5. | Veeva Systems Inc. | $165.91 | 30.52 | $27.21 B | — | 12.48% | 13.93% | $310.5 / $148.05 | $44.05 |
| 6. | TruBridge, Inc. | $23.18 | 77.96 | $339.43 M | — | 6.05% | 2.52% | $26.74 / $13.88 | $12.25 |
| 7. | Heartflow, Inc. | $31.38 | — | $2.69 B | — | -20.2% | -1.11% | $41.22 / $20.13 | $3.52 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 541.17 M | 580.42 M | 521.15 M | 480.1 M | 460.9 M | — |
| Operating Profit | 11.28 M | 14.4 M | 3.34 M | 5.22 M | 5.25 M | — |
| Net Profit | 9.15 M | 6.86 M | 2.69 M | 4.22 M | 4.4 M | — |
| EPS in Rs | 0.07 | 0.05 | 0.02 | 0.03 | 0.04 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.12 B | 1.74 B | 1.66 B | 1.36 B |
| Operating Profit | 34.23 M | 16.98 M | 20.65 M | -19.12 M |
| Net Profit | 22.92 M | 14.38 M | 23.08 M | -8.59 M |
| EPS in Rs | 0.18 | 0.11 | 0.18 | -0.07 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.37 B | 1.14 B | 999.9 M | 792.81 M |
| Total Liabilities | 578.43 M | 452.34 M | 392.51 M | 273.76 M |
| Equity | 737.22 M | 635.18 M | 561.44 M | 499.09 M |
| Current Assets | 911 M | 834.82 M | 700.8 M | 551.96 M |
| Current Liabilities | 568.52 M | 449.15 M | 386.95 M | 264.27 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 163.4 M | 109.28 M | 80.78 M | 47.2 M |
| Investing CF | -181.57 M | -11.98 M | -42.97 M | -0.1 M |
| Financing CF | 6.7 M | 4.33 M | 3.71 M | -19.68 M |
| Free CF | 163.4 M | 109.28 M | 80.78 M | 47.2 M |
| Capex | — | — | -0.11 M | -0.1 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 4.74% | 22.19% | — | — |
| Earnings Growth % | -37.67% | 368.83% | — | — |
| Profit Margin % | 0.83% | 1.39% | -0.63% | — |
| Operating Margin % | 0.98% | 1.25% | -1.41% | — |
| Gross Margin % | 10.19% | 9.74% | 9.93% | — |
| EBITDA Margin % | 1.4% | 1.64% | -1.07% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.